The Nucleic Acid-Based Therapeutics market was valued at USD 4.94 Billion in 2024 and is expected to reach USD 14.38 Billion by 2032, growing at a CAGR of 14.29% (2025-2032). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.